Navigation Links
Voices Against Brain Cancer Discusses New Brain Tumor Vaccine HSPPC-96
Date:12/27/2013

New York, NY (PRWEB) December 27, 2013

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by Medical News Today that discusses a new brain cancer vaccine called HSPPC-96, which is personally molded to each patient’s genetic makeup.

According to the December 19th article published by Medical News Today titled “Promising results for personalized brain tumor vaccine,” patients with Gliobastoma Multiforme (GBM) brain tumors, when going through standard treatment, have a median survival rate of three to nine months. The new vaccine is developed specifically to each patient using his or her own respected tumor tissue. Investigators say the vaccine works by “prompting an immune system response unique to each patient, which sets out to kill any remaining tumor cells following surgery.”

The article states that 90 percent of patients lived after six months of treatment with this vaccine, while 30 percent lived after one year. However, more research is needed before receiving approval to use this treatment for GBM’s.

Researchers have to determine if the vaccine is safer and more effective when used alongside Avastin, a drug that is standard for therapy against GBM’s and known to reduce tumor size.

Michael Klipper, Chairman of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, believes that with more research, this vaccine could be very helpful. “Evidently, additional extensive research has to be done with this vaccine. If results are consistently positive, this vaccine could be a game changer in the treatment of these deadly and aggressive brain tumors,” he says. “Regardless, the fact that this type of treatment is even a possibility, serves as a glimmer of hope for everyone in the brain cancer community.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, Johns Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For press inquiries, please contact: 5W Public Relations.

#####

Read the full story at http://www.prweb.com/releases/2013/12/prweb11445639.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Voices Against Brain Cancer Hosts Contest on Facebook to Recognize Neurosurgeons and Nurses
2. Voices Against Brain Cancer Commends Baseball Coach’s Perseverance to Live a Full Life
3. National Voices for Equality, Education and Enlightenment (NVEEE) to Host 3rd Annual “Not on My Watch” VIP Reception Benefiting Bullying and Suicide Prevention Efforts
4. A New Website for Families to Turn: New Health and Wellness Promotion Website Launched by Family Voices
5. Voices Against Brain Cancer Commends 18-Year-Old Brain Cancer Patient for His Positive Outlook and Will to Live
6. Voices Against Brain Cancer to Host Annual “Join the Voices! Run/Walk” in Partnership with New York Road Runners
7. Voices Against Brain Cancer Commends Tech Startup Co-Founder for Positive Outlook Despite Grim Diagnosis
8. Voices Against Brain Cancer Commends Researchers for the Identification of an Important Protein that May Give Insight to More Effective Glioblastoma Treatments
9. Voices Against Brain Cancer Comments On Breakthrough Brain Surgery Technique
10. Redressing Past Wrongs: Changing the Common Rule to Increase Minority Voices in Research
11. Changing the common rule to increase minority voices in research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect Plugin ... whole new perspective by using the title layers in ProSlice Levels to split-up ... Levels contains over 30 Different presets to choose from. FCPX users can ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: